Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acute Kidney Injury | 10 | 2015 | 709 | 1.690 |
Why?
|
| Renal Replacement Therapy | 2 | 2009 | 70 | 0.680 |
Why?
|
| Critical Illness | 3 | 2013 | 663 | 0.620 |
Why?
|
| Urinary Bladder Neck Obstruction | 1 | 2013 | 21 | 0.460 |
Why?
|
| Bioartificial Organs | 1 | 2012 | 3 | 0.440 |
Why?
|
| Liver, Artificial | 1 | 2012 | 5 | 0.440 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2013 | 220 | 0.410 |
Why?
|
| Nephrology | 1 | 2012 | 50 | 0.400 |
Why?
|
| Statistics as Topic | 1 | 2012 | 307 | 0.380 |
Why?
|
| Acid-Base Imbalance | 1 | 2009 | 6 | 0.350 |
Why?
|
| Ultrasonography | 1 | 2013 | 716 | 0.340 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2009 | 29 | 0.340 |
Why?
|
| Embolism | 1 | 2009 | 43 | 0.330 |
Why?
|
| Evidence-Based Medicine | 2 | 2014 | 693 | 0.330 |
Why?
|
| Hypotension | 1 | 2009 | 120 | 0.310 |
Why?
|
| Nutritional Status | 1 | 2008 | 300 | 0.280 |
Why?
|
| Blood Pressure Determination | 1 | 2007 | 133 | 0.280 |
Why?
|
| Diagnostic Errors | 1 | 2007 | 162 | 0.270 |
Why?
|
| Wounds and Injuries | 1 | 2013 | 772 | 0.270 |
Why?
|
| Biomedical Research | 1 | 2012 | 612 | 0.270 |
Why?
|
| West Nile virus | 2 | 2017 | 38 | 0.260 |
Why?
|
| West Nile Fever | 2 | 2017 | 51 | 0.250 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2017 | 590 | 0.250 |
Why?
|
| Texas | 4 | 2017 | 186 | 0.250 |
Why?
|
| Practice Guidelines as Topic | 2 | 2014 | 1440 | 0.240 |
Why?
|
| Plasma Exchange | 2 | 2014 | 21 | 0.230 |
Why?
|
| Ambulatory Care | 1 | 2007 | 482 | 0.230 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 2674 | 0.200 |
Why?
|
| Kidney | 5 | 2017 | 1357 | 0.200 |
Why?
|
| Hospitalization | 1 | 2009 | 1785 | 0.190 |
Why?
|
| Lupus Nephritis | 1 | 2020 | 55 | 0.190 |
Why?
|
| Cyclophosphamide | 1 | 2020 | 222 | 0.190 |
Why?
|
| Incidence | 3 | 2013 | 2424 | 0.180 |
Why?
|
| Rituximab | 1 | 2020 | 155 | 0.180 |
Why?
|
| Risk Factors | 6 | 2017 | 9003 | 0.170 |
Why?
|
| Hypertension | 1 | 2007 | 1203 | 0.160 |
Why?
|
| Intensive Care Units | 2 | 2013 | 635 | 0.150 |
Why?
|
| Immunosuppressive Agents | 1 | 2020 | 683 | 0.140 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 667 | 0.140 |
Why?
|
| Primary Myelofibrosis | 1 | 2015 | 9 | 0.140 |
Why?
|
| Glomerulonephritis, Membranoproliferative | 1 | 2015 | 14 | 0.130 |
Why?
|
| Comorbidity | 2 | 2013 | 1527 | 0.130 |
Why?
|
| Proteinuria | 1 | 2015 | 99 | 0.130 |
Why?
|
| Protective Agents | 1 | 2014 | 42 | 0.120 |
Why?
|
| Myoglobin | 1 | 2013 | 15 | 0.120 |
Why?
|
| Humans | 16 | 2020 | 119032 | 0.120 |
Why?
|
| Hemofiltration | 1 | 2013 | 31 | 0.120 |
Why?
|
| Prevalence | 3 | 2017 | 2326 | 0.120 |
Why?
|
| Trauma Severity Indices | 1 | 2013 | 127 | 0.110 |
Why?
|
| Causality | 1 | 2013 | 109 | 0.110 |
Why?
|
| Multiple Myeloma | 1 | 2014 | 100 | 0.110 |
Why?
|
| Sorption Detoxification | 1 | 2012 | 3 | 0.110 |
Why?
|
| Extracorporeal Circulation | 1 | 2012 | 15 | 0.110 |
Why?
|
| Dialysis | 1 | 2012 | 24 | 0.110 |
Why?
|
| Middle Aged | 7 | 2017 | 27627 | 0.110 |
Why?
|
| Patient Outcome Assessment | 1 | 2013 | 122 | 0.110 |
Why?
|
| Pyrazoles | 1 | 2015 | 363 | 0.110 |
Why?
|
| Liver Failure | 1 | 2012 | 85 | 0.100 |
Why?
|
| Albumins | 1 | 2012 | 100 | 0.100 |
Why?
|
| Renal Dialysis | 1 | 2014 | 378 | 0.090 |
Why?
|
| Male | 9 | 2020 | 57818 | 0.090 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2015 | 811 | 0.090 |
Why?
|
| Kidney Function Tests | 1 | 2009 | 164 | 0.090 |
Why?
|
| Female | 8 | 2020 | 61588 | 0.080 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 1795 | 0.080 |
Why?
|
| Creatinine | 1 | 2009 | 491 | 0.080 |
Why?
|
| Cholesterol | 1 | 2008 | 375 | 0.070 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2008 | 287 | 0.070 |
Why?
|
| Adult | 5 | 2020 | 31525 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 2874 | 0.070 |
Why?
|
| Hospital Mortality | 1 | 2009 | 814 | 0.070 |
Why?
|
| Health Care Surveys | 1 | 2007 | 546 | 0.060 |
Why?
|
| Retrospective Studies | 2 | 2013 | 12990 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2017 | 5117 | 0.050 |
Why?
|
| Treatment Outcome | 4 | 2020 | 9346 | 0.050 |
Why?
|
| Prognosis | 1 | 2009 | 3443 | 0.050 |
Why?
|
| Immunologic Factors | 1 | 2020 | 225 | 0.040 |
Why?
|
| Aged | 3 | 2013 | 19661 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2020 | 965 | 0.040 |
Why?
|
| Microscopy, Electron | 1 | 2017 | 413 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2007 | 5256 | 0.030 |
Why?
|
| Nitriles | 1 | 2015 | 155 | 0.030 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2014 | 35 | 0.030 |
Why?
|
| Uromodulin | 1 | 2014 | 28 | 0.030 |
Why?
|
| Oliguria | 1 | 2013 | 2 | 0.030 |
Why?
|
| Myoglobinuria | 1 | 2013 | 2 | 0.030 |
Why?
|
| Obesity | 1 | 2007 | 2751 | 0.030 |
Why?
|
| Rhabdomyolysis | 1 | 2013 | 18 | 0.030 |
Why?
|
| Infant | 1 | 2007 | 8295 | 0.030 |
Why?
|
| Adolescent | 2 | 2013 | 18483 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2007 | 9493 | 0.030 |
Why?
|
| Acute-Phase Proteins | 1 | 2012 | 67 | 0.030 |
Why?
|
| Lipocalins | 1 | 2012 | 38 | 0.030 |
Why?
|
| Lipocalin-2 | 1 | 2012 | 64 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2015 | 382 | 0.030 |
Why?
|
| Chemokine CCL2 | 1 | 2012 | 126 | 0.030 |
Why?
|
| Young Adult | 2 | 2020 | 10799 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2013 | 6477 | 0.020 |
Why?
|
| Animals | 1 | 2012 | 33399 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2014 | 968 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2012 | 684 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2012 | 618 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 1474 | 0.020 |
Why?
|
| Child | 1 | 2007 | 19137 | 0.020 |
Why?
|
| Logistic Models | 1 | 2012 | 1901 | 0.020 |
Why?
|
| Time Factors | 1 | 2013 | 6414 | 0.010 |
Why?
|